Stay updated on Safety Tolerability in IPF Clinical Trial

Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Tolerability in IPF Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The clinical trial record for MN-001 (tipelukast) in idiopathic pulmonary fibrosis is available, with study design, participant eligibility, outcome measures, results, dates, and linked protocol documents.
    Difference
    51%
    Check dated 2026-11-08T14:11:35.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error rather than study information.
    Difference
    0.2%
    Check dated 2026-11-01T15:34:31.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T17:11:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:30:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:24:28.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is displayed for the study entry, replacing the normal study record content. This indicates restricted access to the page.
    Difference
    19%
    Check dated 2026-09-20T20:47:44.000Z thumbnail image

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.